Prelude Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$76.8K	Sell	20,700 -1,800	-8%	-$6.68K	0.01%	930
2025 Q1	$72.7K	Buy	+22,500	New	+$72.7K	0.01%	979
2023 Q1	–	Sell	-12,631	Closed	-$281K	–	1165
2022 Q4	$281K	Buy	+12,631	New	+$281K	0.01%	703